logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
PrescriberPoint
HIPAA Logo
HIPAA COMPLIANT
SOC 2 Logo
Soc 2 Type II
PrescriberPoint
HIPAA Logo
HIPAA COMPLIANT
SOC 2 Logo
Soc 2 Type II
For ProvidersRequest DemoJoin Research Panel
Prescribing toolsPrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyPartnershipsAboutCareersContact Us
Get the latest insights in your inbox
  • Terms and Conditions
  • Privacy Policy
  • © 2026 PrescriberPoint. All Rights Reserved.
    1. Home
    2. Indications
    3. Zollingerellison Syndrome

    Medications for Zollingerellison Syndrome

    FiltersReset Filters
    15 results

    • aciphex

      (rabeprazole sodium)
      Waylis Therapeutics LLC
      Usage: ACIPHEX is indicated for the healing and symptomatic relief of erosive or ulcerative GERD, maintenance of GERD healing, treatment of symptomatic GERD, healing of duodenal ulcers, eradication of Helicobacter pylori to reduce duodenal ulcer recurrence, long-term treatment of pathological hypersecretory conditions, and treatment in adolescents aged 12 and older.

    • esomeprazole magnesium

      (Esomeprazole magnesium)
      Granules Pharmaceuticals Inc.
      Usage: Esomeprazole magnesium delayed-release capsules are indicated for the short-term treatment of erosive esophagitis, GERD symptoms, risk reduction of NSAID-associated gastric ulcers, H. pylori eradication, and long-term treatment of pathological hypersecretory conditions, including Zollinger-Ellison syndrome in adults and adolescents aged 12-17.

    • esomeprazole magnesium

      (Esomeprazole magnesium delayed release capsules)
      Ascend Laboratories, LLC
      Usage: Esomeprazole magnesium delayed-release capsules are indicated for the healing and maintenance of erosive esophagitis, treatment of symptomatic GERD, gastric ulcer risk reduction from NSAID therapy, H. pylori eradication, and long-term treatment of pathological hypersecretory conditions like Zollinger-Ellison Syndrome in adults and adolescents aged 12-17.

    • esomeprazole magnesium

      (Esomeprazole Magnesium)
      Aurobindo Pharma Limited
      Usage: Esomeprazole magnesium is indicated for the short-term treatment of erosive esophagitis, symptomatic GERD in adults and pediatric patients (12-17 years), maintenance of healing of erosive esophagitis, reducing NSAID-associated gastric ulcers, eradicating H. pylori to prevent duodenal ulcers, and long-term treatment of Zollinger-Ellison Syndrome.

    • esomeprazole magnesium

      (Esomeprazole Magnesium)
      Aurobindo Pharma Limited
      Usage: Esomeprazole magnesium for delayed-release oral suspension is indicated for healing erosive esophagitis, treating GERD symptoms, reducing NSAID-associated gastric ulcers, eradicating Helicobacter pylori to prevent duodenal ulcer recurrence, and long-term treatment of pathological hypersecretory conditions like Zollinger-Ellison Syndrome in various age groups.

    • pantoprazole

      (Pantoprazole)
      NorthStar RxLLC
      Usage: Pantoprazole sodium delayed-release tablets are indicated for the short-term treatment of erosive esophagitis associated with GERD, maintenance of its healing, and for the long-term treatment of pathological hypersecretory conditions, including Zollinger-Ellison Syndrome, in adults and pediatric patients aged five and older.

    • pantoprazole sodium

      (Pantoprazole sodium)
      Ajanta Pharma USA Inc.
      Usage: Pantoprazole sodium for delayed-release oral suspension is indicated for the short-term treatment of erosive esophagitis associated with GERD, maintenance of healing and reduction of heartburn relapse, and long-term treatment of pathological hypersecretory conditions, including Zollinger-Ellison Syndrome, in adults and pediatric patients aged five and older.

    • pantoprazole sodium

      (pantoprazole sodium)
      Granules Pharmaceuticals Inc.
      Usage: Pantoprazole sodium delayed-release tablets are indicated for short-term treatment of erosive esophagitis due to GERD in adults and children (5+), maintenance of healing in adults, and long-term treatment of pathological hypersecretory conditions, including Zollinger-Ellison Syndrome. Treatment duration varies based on condition and patient age.

    • pantoprazole sodium

      (PANTOPRAZOLE)
      Quallent Pharmaceuticals Health LLC
      Usage: Pantoprazole sodium delayed-release tablets are indicated for the short-term treatment of erosive esophagitis due to GERD, maintenance of healing and symptom relief in adults, and long-term treatment of pathological hypersecretory conditions, including Zollinger-Ellison Syndrome. Usage in pediatric patients is limited to 8 weeks.

    • pantoprazole sodium

      (Pantoprazole Sodium)
      Chartwell RX, LLC
      Usage: Pantoprazole Sodium Delayed-Release Tablets are indicated for short-term treatment of erosive esophagitis associated with GERD, maintenance of healing of erosive esophagitis, and long-term management of pathological hypersecretory conditions, including Zollinger-Ellison syndrome in adults and pediatric patients over five years old.